Immunotherapy delays type 1 diabetes diagnosis in people at high risk - Pharmafield
Drug delays type 1 diabetes in people at high risk | National Institutes of Health (NIH)
New drug delays type 1 diabetes by more than a year, study reports
Game Changer: Antibody First to Delay Type 1 Diabetes Onset in TrialNet
Drug that targets the immune system can delay type 1 diabetes in high risk children, adults
Breakthrough type 1 diabetes drug trial delays disease after just 14 days - SlashGear
In milestone trial, experimental drug delays type 1 diabetes | Science | AAAS
Scientists Have Developed a Treatment to Delay Type 1 Diabetes Among People at High Risk - News18
Drug delays type 1 diabetes in people at high risk: Study | Greater Kashmir